After Spent Years Rejecting, FDA Approves Flavored Vapes
The FDA approved two fruit-flavored vape lines from a Los Angeles company, a notable policy reversal that comes as po...
Fundamentals cover assigning every dollar a role, regular review, and disciplined adjustments to keep your finances on track.
18,222 articlesThe FDA approved two fruit-flavored vape lines from a Los Angeles company, a notable policy reversal that comes as po...
Magnolia (MGY) is delivering a pivotal Q1 2026 performance that tests the durability of its business model. This arti...
Coinbase stunned markets with an unexpected loss even as its newer businesses are scaling rapidly. This article expla...
Blunt, no-nonsense commentary from public figures can spark real lessons for money. This article draws practical fina...
Two popular ETFs compete for your attention: a low-cost, broad staples fund and a concentrated food-and-beverage tilt...
As FSK gears up for its 2026 earnings call, investors should focus on revenue growth, margins, and capital allocation...
Circle’s ARC presale unlocks a $3 billion fully diluted valuation and signals a broader push into institutional finan...
Fan tokens are shifting from novelty to data assets, with clubs using on chain activity to measure sentiment, reward ...
MSGM's Q1 2026 commentary offers a clearer view of the year ahead for investors. This article decodes the msgm 2026 e...
As the first quarter of 2026 unfolds, invivyd ivvd 2026 earnings take center stage for investors watching the biotech...
Lane Generational just disclosed a sizeable stake in Evolv Technologies, signaling potential interest from big invest...
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...